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PURPOSE To assess the long-term refractive and biometric outcomes of diode laser-treated eyes in
threshold retinopathy of prematurity (ROP).
METHODS Cycloplegic autorefraction and biometry (Zeiss IOLMaster) were performed, at a mean
follow-up of 11 years, on 16 laser-treated eyes with threshold ROP and 9 comparison eyes
with subthreshold untreated ROP.
RESULTS The laser-treated eyes had a mean spherical equivalent of2.33 D with a mean astigmatic
error of 1.38 D. The comparison eyes had a mean spherical equivalent of 1.07 D with
a mean astigmatic error of 0.42 D. This trend toward increased myopia in treated eyes did
not achieve statistical significance ( p0.08). The myopia in the laser group appeared to
be slowly progressive in nature when compared with earlier refractive data for these
patients. The laser-treated eyes had reduced anterior chamber depth (ACD) compared
with the subthreshold eyes ( p0.02). When physiologic accommodation was inhibited by
cycloplegic drops, the anterior chamber deepened by 0.13 mm in the laser-treated eyes
and by 0.06 mm in the comparison eyes. This effect of accommodation on ACD did not
differ significantly between the two groups ( p0.23). The laser-treated eyes and the
comparison eyes did not differ significantly in terms of axial length, corneal power, corneal
diameter, or lens power. However, both groups had steeper corneas, shallower anterior
chambers, and shorter axial lengths when compared with historical full-term controls.
CONCLUSIONS Myopia in premature infants requiring laser treatment for ROP is associated with a
shallowing of the anterior chamber and a steepening of the cornea. Physiological accom-
modation is not impaired by laser therapy or by severe ROP. ( J AAPOS 2006;10:
454-459)P rematurity and retinopathy of prematurity (ROP)are well-established independent risk factors formyopia.1-4 There have been reports that cryother-
apy in threshold ROP contributes to the development of
myopia and that laser photocoagulation, in comparison,
produces less myopic shift.5-7 However, Quinn et al felt
that the cryotherapy did not result in additional myopia
but that the high myopia was related to the cicatricial
retinopathy or severity of ROP.8 In recent times, laser
photocoagulation has largely replaced cryotherapy as the
established treatment modality for ROP. Davitt et al have
shown no increase in myopia or high myopia, at 9 months,
in laser-treated compared with untreated high-risk preth-
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454reshold ROP eyes in the Early Treatment of Retinopathy
of Prematurity (ETROP) study.9
The clinical objective of this study was to evaluate the
long-term refractive outcome of threshold ROP eyes at a
mean of 11 years after diode laser treatment, with partic-
ular attention to the role of the cornea, anterior chamber
depth, axial length, and effective lens power in determin-
ing the refractive status.
A comparison group with documented subthreshold
ROP, which had regressed spontaneously without laser
treatment, was also evaluated.
Materials and Methods
All premature babies who received diode laser photocoagulation
for threshold retinopathy of prematurity (n41), between De-
cember 1991 and December 1995, at the neonatal unit of The
National Maternity Hospital, Dublin were identified from a
register of children treated for ROP. These dates were chosen
because the diode laser was first introduced in this unit in De-
cember 1991 and we wished to have a minimum of 9 years of
follow-up for our study population. Laser treatment was placed,
under sedation, anterior to the fibrovascular ridge in accordance
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treatment.10
Four babies died before the age of 9 months (deaths not related
to laser treatment). Records were not available on another four
children, one of whom was known to have returned to Russia
shortly after laser treatment. Thirty-three patients were eligible
for entry into this study. It was not possible to trace eight of the
children. Their parents were not contactable by phone, by letter,
or through their general practitioners and had most likely moved
without forwarding contact information. Thus 25 patients were
contactable. All were recruited and reviewed with informed pa-
rental consent.
Eighteen patients, also with 9 or more years follow-up, with
subthreshold ROP (at least stage 2, zone II ROP with spon-
taneous regression) were identified from a log book of babies
screened for ROP in the neonatal unit (screening criteria of
31 weeks gestational age or 1500 g birth weight). These
children were selected for inclusion in the study with view to
having a comparison group which closely matched the study
population in terms of prematurity and severity of ROP.1,2 Six
of these children were not contactable, and there were three
parental refusals. The remaining nine children participated in
the study.
The patients were recalled to the eye clinic at the Children’s
Hospital for assessment. Best-corrected distance visual acuity was
recorded using a back-illuminated Distance Early Treatment of
Diabetic Retinopathy Study (ETDRS) chart (Lighthouse Inc.,
New York, NY) at a test distance of 4 m. Visual acuity was
estimated as the logMAR value of the last line on which the child
could correctly identify three of the five available letters. Biom-
etry was performed in the accommodative dynamic state (without
dilating drops) using the IOLMaster (Carl Zeiss, Jena). Corneal
diameter, corneal power, anterior chamber depth (ACD), and
axial length (AL) were all measured. The average of the K1 and
K2 readings was defined as the mean K reading (corneal power)
of that eye. The SRK-T formula was used to calculate the
effective lens power (LP) for each eye. Cyclopentolate 1% was
subsequently instilled in both eyes and, after 30 minutes, the
biometry was repeated (nonaccommodative static state). A desk-
top autorefractometer (Model AR-630A, Nidek Co., Ltd., Japan)
was then used to evaluate the cycloplegic refraction. The sphere,
positive cylinder, and axis were measured for each eye and the
spherical equivalent (SE) was recorded (spherehalf cylinder
value). Demographic information was obtained from hospital
records and details regarding the laser treatment were ascer-
Table 1. Baseline characteristics of the study population
Variable Laser group (16 eyes)
GA in weeks (mean  SD) 26.6 1.7
BW in grams (mean SD) 890.0 207.7
Follow-up in years (mean SD) 11.1 0.9
BCDVA (mean  SD) 0.17 0.31
Gender (number/%)
Male 10 (63)
Female 6 (37)
GA: gestational age; BW: birth weight; SD: standard deviation; BCDVA: Best-corretained from the register of treated children.
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For statistical purposes, only one eye per patient in both the laser
and comparison groups was included in the comparative analysis
of the effect of diode laser on refractive and biometric outcomes.
The right eye was chosen in all cases where data were available
for both eyes. Analysis was performed using MATLAB® 6.5
(Statistics Toolbox 4.0). As the demographic and refractive data
were normally distributed, the parametric Student’s t-test was
used to compare continuous outcomes. The biometric data were
not normally distributed; consequently, continuous outcomes
were compared using the nonparametric Wilcoxon rank-sum
test. Fisher’s Exact test was used to compare categorical out-
comes. A p-value of less than 0.05 was considered significant.
Results
Of the 25 laser-treated children recruited for this study,
three had cerebral palsy, three had marked manifest nys-
tagmus, and one had limited mobility. These patients were
excluded as they were unable to cooperate with the IOL-
Master examination. As all 9 children in the subthreshold
ROP comparison group had normal retinal appearance
with a history of regressed Zone II ROP, a further 2
patients were excluded from the laser group—one with
bilateral retinal detachments due to Zone I ROP and one
with a macular fold. Therefore, 16 laser-treated eyes with
normal retinal appearance were included in the study
analysis.
The baseline characteristics of both the laser and the
subthreshold ROP groups are outlined in Table 1. The
gestational age for the study population as a whole ranged
from 24 to 30 weeks and the birth weight ranged from 620
to 1398 g. The duration of follow-up for these children
ranged from 9.0 to 12.8 years. There were no statistically
significant differences in the means between the laser
group and comparison group with respect to gestational
age, birth weight, follow-up, and best-corrected distance
visual acuity. Neither was there a significant difference in
sex distribution between the 2 groups.
Laser Treatment Details
The number of laser burns per eye ranged from 303 to
1261, with a mean of 716287 burns. The power ranged
from 300 to 750 mW (median 325 mW) and the duration
parison group (9 eyes) Laser versus comparison ( p-value)
27.4  1.5 0.21
972.6 230.6 0.37
11.2  1.4 0.83
0.04 0.10 0.06
7 (71) 0.37
2 (29) 0.37
tance visual acuity.Comof each burn ranged from 200 to 500 ms (median 200 ms).
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eye to achieve regression of ROP.
Refractive Outcome
Figure 1 illustrates the refractive outcome of the study
population. Although the laser-treated eyes were more
myopic than the subthreshold ROP eyes (mean spherical
equivalents of 2.33 and 1.07 D, respectively), this dif-
ference did not reach statistical significance ( p0.08).
However, there was a significant difference in terms of
mean astigmatic error (1.38 and 0.42 D, respectively,
p0.007). The mean plus cylinder axis was 91° for the
laser-treated eyes and 65° for the subthreshold ROP eyes
with both groups having predominantly against-the-rule
astigmatism.
Fifty percent of laser-treated eyes were myopic (mean
SE of these eyes, 6.45 D) compared with 22.2% of eyes
in the comparison group (mean SE, 0.75 D). The dis-
tribution of myopia in both groups is given in Figure 2.
Biometric Outcome
Analysis of the biometric data was performed on the re-
FIG 1. Refractive outcome of the study population.
FIG 2. Distribution of myopia in the study population.sults obtained after cycloplegia to eliminate any variationin the biometric parameters which may have occurred due
to accommodation. These findings are given in Table 2.
There was a statistically significant difference in ACD
( p0.02) between the laser-treated and subthreshold
ROP eyes. However there was no difference in terms of
axial length, corneal power, corneal diameter, or lens
power between the 2 groups. In other words, the eyes that
received diode laser treatment had shallower anterior
chambers than the comparison eyes in which the sub-
threshold ROP had spontaneously regressed.
When paired sample testing was performed on the bio-
metric data for the study eyes in the dilated nonaccom-
modative state and the undilated accommodative state, the
only study parameter that demonstrated a statistically sig-
nificant change was the ACD. When physiological accom-
modation was inhibited by the cycloplegic drops, the ACD
deepened in the laser eyes by a median difference of 0.13
mm ( p0.001) and in the comparison eyes by a median
difference of 0.06 mm ( p0.039) as illustrated in Figure
3. However, the effect of accommodation on ACD did not
differ significantly between the two groups ( p0.23).
Discussion
It is now recognized that ROP and prematurity-induced
myopia cannot be fully explained by increased axial length
and that anterior segment arrest contributes to the in-
creased myopia seen in these conditions.11-13 This is the
first study to use the Zeiss IOLMaster to analyze the
various biometric elements that collectively determine the
refractive status of an eye in a cohort of premature chil-
dren treated with diode laser photocoagulation for thresh-
old ROP. The IOLMaster is based on an optical measure-
ment technique known as partial coherence interferometry
and produces results for axial length measurement that
have been shown to be as accurate as immersion ultra-
sound findings and superior to applanation ultrasound
biometry.14-16 It has the added advantage of being a non-
contact technique, rendering it particularly useful in the
assessment of children. Kriechbaum et al demonstrated
that the IOLMaster is also a reliable method of ACD
measurement in phakic eyes.17 The ACD values are sig-
nificantly higher with this noncontact technique compared
with the more frequently reported applanation ultrasound
values.15,17,18
An ideal control group for this study would consist of
patients with threshold ROP randomized to observation
without laser treatment. However, in light of the unequiv-
ocal benefit of treatment demonstrated in the CRYO-
ROP study, this is obviously unethical.19 In view of this,
we selected age-matched comparison eyes with significant
ROP (stage 2 or more ROP in zone II), which failed to
reach threshold level and which regressed spontaneously.
Our refractive outcome results showed that the laser
group was more myopic than the comparison group with
mean spherical equivalents of 2.33 D (SD 5.21) and
1.07 D (SD 2.72), respectively. However, this difference
Journal of AAPOS
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trated in Figure 1, there is a much wider variation of
refractive error among the laser-treated patients as com-
pared with the subthreshold ROP patients. Of the laser-
treated eyes 37.5% had more than 4 D of myopia, whereas
none of the comparison eyes had more than 4 D of myo-
pia. Kent et al assessed the refractive error in premature
babies across the spectrum of ROP stages, including sub-
threshold and laser-treated stage 3 ROP.20 Comparison of
refractive error between stage 0 and stage 3 subthreshold
eyes in their study showed no difference but there was a
marked difference between stage 0 and stage 3 laser-
treated eyes. As our comparison eyes had subthreshold
ROP, we are unable to determine whether this observed
difference in refractive error is attributable to the fact that
the laser-treated eyes had more severe (threshold) ROP
from the outset or whether the laser treatment itself con-
tributed to the increased myopia. Recent ETROP findings
would indicate that the increased myopia in laser-treated
patients is in fact due to the more severe ROP in these
patients rather than any direct effect of the laser treat-
FIG 3. Effect of accommodation on anterior chamber depth (ACD). When
physiological accommodation was inhibited by the cycloplegic drops
(ACD), the ACD deepened significantly in both the laser ( p 0.001) and
the control ( p  0.039) eyes. However, the effect of accommodation on
ACD (ie, ACD-ACD) did not differ significantly between the two groups
( p  0.23).
Table 2. Comparison of biometric outcomes (after cycloplegia)
Variable
Laser group (16 eyes)
Mean SD
Spherical equivalent (D) 2.33 5.21
Axial length (mm) 22.81 1.88
Anterior chamber depth (mm) 3.38 0.25
Corneal power (D) 45.24 1.30
Corneal diameter (mm) 11.85 0.30
Lens Power / SRK-T (D) 21.80 6.19
SD: standard deviation.ment.9 There was a significant difference in terms of mean
Journal of AAPOSastigmatic error between our laser-treated and untreated
subthreshold ROP eyes (1.38 and0.42 D, respectively,
p0.007). Kent et al and Laws et al have also reported
increasing astigmatism with increasing stage of ROP.20,21
It is encouraging to note that the mean spherical equiv-
alent and mean astigmatic error outcomes for our laser-
treated eyes compare favorably with the findings of other
investigators, as presented in Table 3.7,20,22-24 The short-
term refractive outcome at 1, 2, and 3 years has previously
been reported for the laser-treated patients in our study.25
In the earlier reports, as in this study, all unilateral cases
and only the right eyes of cases where treatment was
bilateral were selected for inclusion in the refractive anal-
ysis. We see from Table 4 that the overall percentage of
patients with myopia does not seem to increase signifi-
cantly with time. However, the refractive error, in those
patients who develop myopia at an early age, appears to be
slowly progressive. This is consistent with previously pub-
lished reports describing a trend of increasing myopia in
laser-treated patients.4,7,20
The Collaborative Longitudinal Evaluation of Ethnicity
and Refractive Error (CLEERE) Study Group has dem-
onstrated a significant effect of age on refractive error and
ocular biometric parameters between the ages of 6 and 14
years.26 We have therefore chosen to compare our bio-
metric findings with those in the literature for similarly
aged full-term children and similarly aged preterm chil-
dren with and without threshold ROP (Table 5). There is
no evidence of an association between increasing AL and
either prematurity or severity of ROP in this historical
data. In fact, mean AL appears to be shorter in the sub-
threshold ROP and threshold ROP eyes compared with
those with no ROP, indicating that the myopia in these
patients is nonaxial in nature.
Our laser-treated eyes had significantly shorter ACDs
( p0.02) than our subthreshold ROP eyes. The historical
data in Table 5 also show a trend of reducing ACD with
increasing severity of ROP. Shallowing of the anterior
chamber would give rise to a more anteriorly placed lens
and could account for the increased myopia seen in the
laser-treated eyes. Although Kent et al also observed a
trend toward a shallower anterior chamber in stage 3
treated eyes compared with stage 3 subthreshold eyes, this
did not reach statistical significance.20 In their study, bio-
Comparison group (9 eyes) Laser versus comparison
n Mean SD Median p value
0 1.07 2.72 0.38 0.08
5 22.47 1.60 22.90 0.97
6 3.70 0.49 3.87 0.02
0 44.82 0.98 45.00 0.52
0 12.06 0.57 12.15 0.24
0 23.50 5.83 21.25 0.97Media
0.5
22.0
3.4
45.0
11.8
24.0metric assessment was performed by a “through-the-lid”
th.
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luded to earlier, applanation ultrasound methods can lead
to a shallowing of the anterior chamber and less reliable
ACD measurements.
There was no significant difference between our laser-
treated eyes and our comparison eyes in terms of corneal
power (mean Ks of 45.24 D versus 44.82 D, respectively,
p0.52). However, both groups had steeper corneas than
expected when compared with data for historical full-term
normal eyes (mean K of 42.99 D), supporting the concept
of anterior segment arrest in premature eyes with ROP.13
There was also no significant difference in lens power
between our laser and control eyes (mean LP of 21.8 D
versus 23.5 D, respectively, p0.97). Our findings did not
differ significantly from the mean calculated lens power
values reported recently by Zadnik et al for 11-year-old
children (mean LP for girls of 22.71 D and for boys of
21.82 D).26 Connolly et al reported a mean LP of 22.8 D
for laser-treated eyes at a mean follow-up of 10 years.7
However, following a comparison with a historical mean
lens power of 18.9 D reported by Gordon and Donzis in
the 1980s for 10- to 15-year-old full-term children, they
hypothesized that crystalline lens power is a major com-
ponent of the refractive error seen in these eyes.27 They
also postulated that the tissue destruction associated with
Table 3. Summary of studies on long-term refractive outcome of laser t
Study No. of eyes Type of laser Mean foll
Sahni et al22 81* Argon and diode
Kent et al20 21* Unspecified
Ospina et al23 42* Argon
Shalev et al24 10† Diode
Connolly et al7 20† Argon and diode
Our study 16† Diode 1
*Both eyes of same patient included in analysis.
†Only one eye per patient included in analysis.
Table 4. Refractive outcome of laser-treated eyes at 1, 2, 3, and 11 ye
Follow-up ( yr) No. of laser patients Mean spherical equi
1 26 0.21
2 21 0.63
3 11 0.49
11 16 2.33
Table 5. Comparison of our mean biometric outcomes with data from th
Study population
Follow-up
( y)
No. of
eyes
Full-term, no ROP (Fledelius, 1976) 10.2 67
Pre-term, no ROP (Fledelius, 1996) 8.9 28
Pre-term, subthreshold ROP (Our
comparison group, 2005)
11.2 9
Pre-term, laser-treated, threshold
ROP (Our laser group, 2005)
11.1 16
Pre-term, laser-treated, threshold
ROP (Connolly et al, 2002)
9.9 20
SE: spherical equivalent; D: diopters; AL: axial length; ACD: anterior chamber deplaser treatment of the peripheral retina might in some wayalter the maturation of the zonules, ciliary body, or lens
itself, thus accounting for the apparent failure of em-
metropization in these eyes and resultant failure of reduc-
tion in lens power with aging. In light of this, we decided
to look at the effect, if any, of laser therapy on accommo-
dation in threshold ROP eyes. Physiologic accommoda-
tion results in an increase in lens thickness and the forward
movement of the anterior lens surface leading to a short-
ening of the ACD. When the biometric data for the study
eyes in the dilated nonaccommodative state were com-
pared with the data from the undilated accommodative
state, the ACD was seen to have shortened by 0.13 mm
( p  0.001) in the laser-treated eyes and by 0.06 mm
( p0.039) in the untreated subthreshold eyes with active
accommodation (Figure 3). The effect of accommodation
on ACD did not differ significantly between the laser-
treated eyes and the control eyes ( p0.23), indicating that
neither laser therapy nor severe ROP had any adverse
effect on the mechanism of accommodation.
Our study has several limitations: the numbers are rel-
atively small; our comparison group had less severe ROP
from the outset; and, due to cognitive impairment, several
patients were unable to cooperate with biometric assess-
ment. While we recognize these limitations, we neverthe-
less feel that this study provides valuable information re-
for ROP
( yr) Mean spherical equivalent (D) Mean cylinder power (D)
2.40 —
2.35 —
4.95 2.00
6.50 —
4.56 1.28
2.33 1.38
D) Myopic patients (%) Mean SE of the myopic eyes (D)
38.5 1.79
42.9 2.83
45.5 3.03
50.0 6.45
ture for similarly-aged children
E
)
AL
(mm)
ACD
(mm)
Corneal power
(D)
Lens power
(D)
.61 23.50 3.90 42.99 —
.93 22.98 3.98 44.00 —
.07 22.47 3.70 44.82 23.50
.33 22.81 3.38 45.24 21.80
.56 22.89 3.44 46.68 22.80herapy
ow-up
3.0
3.4
6.2
7.0
9.9
1.1ars
valent (e litera
S
(D
0
0
1
2
4garding the long-term refractive and biometric outcomes
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a mean follow-up of 11 years, our laser group had a mean
spherical equivalent of 2.33 D with a mean astigmatic
error of 1.38 D. The myopia appeared to be slowly pro-
gressive in nature when compared with earlier refractive
data for these patients. The laser-treated eyes had shal-
lower anterior chambers than the comparison eyes in
which the subthreshold ROP spontaneously regressed.
However the two groups did not differ significantly in
terms of axial length, corneal power, corneal diameter, or
lens power. Physiological accommodation was not im-
paired in the laser-treated eyes.
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